Related references
Note: Only part of the references are listed.Maintenance Therapy for Advanced Non-small Cell Lung Cancer: Current Status, Controversies, and Emerging Consensus
Taofeek K. Owonikoko et al.
CLINICAL CANCER RESEARCH (2010)
Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study
Federico Cappuzzo et al.
LANCET ONCOLOGY (2010)
Impact on survival of 12 versus 3 monthly cycles of paclitaxel (175 mg/m2) administered to patients with advanced ovarian cancer who attained a complete response to primary platinum-paclitaxel: Follow-up of a Southwest Oncology Group and Gynecologic Oncology Group phase 3 trial
Maurie Markman et al.
GYNECOLOGIC ONCOLOGY (2009)
Duration of Chemotherapy for Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Trials
Yu Yang Soon et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
Tudor Ciuleanu et al.
LANCET (2009)
Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer:: A gynecologic cancer intergroup trial of the AGO-OVAR and GINECO
Jacobus Pfisterer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Epidoxorubicin versus no treatment as consolidation therapy in advanced ovarian cancer: results from a phase II study
G Bolis et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published randomized controlled trials
H Bozcuk et al.
CANCER (2005)
Maintenance treatment with interferon for advanced ovarian cancer: results of the Northern and Yorkshire gynaecology group randomised phase III study
GD Hall et al.
BRITISH JOURNAL OF CANCER (2004)
Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma:: A randomized trial of the Gynecologic Oncology Group
MA Varia et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group trial
M Markman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
A case of chronic paclitaxel administration in ovarian cancer
VE von Gruenigen et al.
GYNECOLOGIC ONCOLOGY (2003)
Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trial
TS Maughan et al.
LANCET (2003)
Chronic administration of single-agent paclitaxel in gynecologic malignancies
J Rohl et al.
GYNECOLOGIC ONCOLOGY (2001)
Share Paper
